Travel Health Evidence

Conradh

Dhiarrhoea na n-imreoirí: cad a choinníonn é

Oibríonn prophylaxis níos lú go héifeachtach ná mar a léiríonn na táirgí, agus tá sé níos tábhachtaí a bheith ar an eolas faoi cad atá le déanamh nuair a tharlaíonn sé ná é a chosc.

Nuashonraithe 3 min léamh 17 tagairtí Láidir an fhianaise 4/5

Cad a bhaint amach le prophylaxis

Déantar anailísí meitice ar prophylaxis probiotics [1][3][4] agus ar probiotics i gcomparáid le rifaximin [2] a fháil laghdú measartha ar an gcion. Is é measartha an focal oibríochta: is laghdú riosca coibhneasta atá i gceist i gcoinníoll coitianta, ní cosaint.

Ní mholtar prophylaxis antaibheathach go ginearálta do thaistealóirí gnáth. Cuireann sé le frithsheasmhacht, tá fo-iarsmaí aige, agus spreagann sé colún le horgánaigh frithsheasmhaigh a thugann taistilóirí abhaile — costais leibhéal daonra a íocann le haghaidh áisiúlacht leibhéal aonair.

Prophylaxis do dhiarrhoea na n-imreoirí

Bearta bia agus uisce

"Bóthar é, cócaráil é, peel é nó dearmad é" tá sé cuimhneacháin agus ní héifeachtach ach go páirteach — faightear staidéir ar choinneáil a léiríonn go bhfaigheann taistilóirí a leanann na rialacha go dlúth tinn ag rátaí suntasacha, go príomha toisc go dtarlaíonn an nochtadh i gcistineacha nach féidir leo a fheiceáil.

Is iad na bearta a bhfuil an toradh is fearr acu: uisce buidéalaithe nó cóireáilte lena n-áirítear do shúile, ag seachaint oighear nach bhfuil a fhoinse ar eolas, bia te a sheirbheáil te seachas a choinneáil te, agus torthaí a peelann tú féin. Déanann sláinte láimhe roimh ithe níos mó ná an chuid is mó de sheachaint bia.

Nuair nach bhfuil sé ach dhiarrhoea na n-imreoirí

  • Fuil sa stól nó teochtaí ard. Cuardaigh cúram leighis seachas féin-chóireáil.
  • Comharthaí a mhaireann níos faide ná seachtain. Smaoinigh ar chúiseanna parastaí, a theastaíonn cóireáil dhifriúil.
  • Díhiodráitiú trom, go háirithe i leanaí agus taistilóirí níos sine.
  • Comharthaí a thosaíonn tar éis duit filleadh. Inis don chliniceoir cá háit a raibh tú; athraíonn sé an difreáil.
  • Comharthaí leanúnacha tar éis eipeasóid ghéar. Tá IBS iar-ionfhabhtaithe mar thoradh aitheanta agus faoi dhiagnóisiú.

Tá an pointe deireanach sin tuillte: tá mionlach suntasach ag forbairt comharthaí gafa buan tar éis eipeasóid ionfhabhtaithe. Más rud é nach dtagann do ghoile ar ais go gnáth tar éis turas, is feiniméan aitheanta é sin agus ní rud a d'inis tú — féach ar ár suíomh fianaise ghoile-ghréine.

Ceisteanna coitianta

An gcaithfidh mé probiotics a thógáil roimh thuras?
Faigheann anailísí meitice laghdú measartha [1][2]. Riosca íseal, costais íseal, dóchas íseal.
An gcaithfidh mé antaibheathach a thógáil go prophylactically?
Go ginearálta ní. Cuireann frithsheasmhacht agus fo-iarsmaí níos mó ná an tairbhe do thuras gnáth.
An bhfuil loperamide sábháilte a úsáid?
Do rialú comharthaí i ngalar neamh-dhorcha, tá. Seachain é le teochtaí nó fuil sa stól.
Cé chomh fada is gá dó a mhaireachtáil?
Réitíonn an chuid is mó de na cásanna laistigh de laethanta cúpla. Thar seachtain, faigh measúnú.

Tagairtí

Gach tagairt thíos a nascann leis an taifead peer-reviewed bunaidh ar PubMed nó trí DOI. Ní rud ar bith anseo a chuireann comhairle leighis in ionad.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis Fagnant HS, Isidean SD, Wilson L, et al. · Advances in nutrition (Bethesda, Md.) · 2023 · Meta-analysis DOIPubMed 36822240Full text
  5. Probiotics and rifaximin for the prevention of travelers' diarrhea: A systematic review and network meta-analysis Fan H, Gao L, Yin Z, et al. · Medicine · 2022 · Meta-analysis DOIPubMed 36221413Full text
  6. Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea Brum JM, Gibb RD, Ramsey DL, et al. · Digestive diseases and sciences · 2021 · Meta-analysis DOIPubMed 32772204Full text
  7. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  8. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  9. Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials Bae JM · Epidemiology and health · 2018 · Meta-analysis DOIPubMed 30189723Full text
  10. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  11. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials Hu Y, Ren J, Zhan M, et al. · Journal of travel medicine · 2012 · Meta-analysis DOIPubMed 23379704
  12. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis Alajbegovic S, Sanders JW, Atherly DE, et al. · Systematic reviews · 2012 · Meta-analysis DOIPubMed 22929178Full text
  13. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review Riddle MS, Sanders JW, Putnam SD, et al. · The American journal of tropical medicine and hygiene · 2006 · Meta-analysis PubMed 16687698
  14. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  15. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  16. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  17. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text

Taispeánadh an leathanach seo go huathoibríoch ó Bhéarla. Ní athraítear na tagairtí agus na huimhreacha. Léigh an t-údarás Béarla má léitear rud ar bith go neamhréireach. Léigh an t-údarás Béarla